Johnson Controls (JCI) · Q4 2026 earnings analysis
Johnson Controls fiscal Q4 2026: orders up 44%, adjusted EPS +32% to $1.66; FY27 guided to $6.15–$6.30
Q4 · Fiscal year 2026 · Published by Pham Hop
Johnson Controls’ fiscal Q4 2026 sales rose 10% to $7.11B (12% organic) and adjusted EPS rose 32% to $1.66 as orders jumped 44% and backlog hit $23.0B; GAAP EPS of $1.60 (from $0.42) is flattered by year-ago charges, and FY2027 adjusted EPS is guided to $6.15–$6.30.
At a glance
- Orders +44%, backlog $23.0B (+43%). Signed work now equals nearly eleven months of fiscal 2026 sales ($25.67B), which is what backs the 11% to 12% organic growth guided for fiscal 2027.
- GAAP EPS $1.60, up from $0.42. Most of that jump is the year-ago quarter's $400M restructuring and impairment charge and a $102M IT write-down not recurring; the like-for-like gain is the 32% in adjusted EPS.
- Every region's margin rose. Adjusted segment EBITA margin went from 18.8% to 20.6%, led by the Americas at 22.0% (from 19.9%), where data-center demand is concentrated.
GAAP EPS +281% to $1.60 mostly reflects a year-ago $400M restructuring charge and $102M ERP write-down; adjusted EPS rose 32%, ~4 pts of it from 4% fewer shares
The reported figures look better than the underlying business: one-off gains, a prior-year charge that did not recur, a lower tax rate, buybacks or reserve releases did much of the work.
In this report
Johnson Controls (JCI) sells and services the heating, cooling, fire and security systems inside large buildings, and its fiscal year ends September 30, so the three months to September 30, 2026 are its fiscal Q4 2026. Sales rose 10% to $7.11 billion, and organic sales (growth after stripping out currency swings and businesses bought or sold) rose 12%, ahead of the 9% to 10% management had guided. Adjusted EPS, the company's own measure that excludes items it treats as one-offs, rose 32% to $1.66 against guidance of about $1.55. Orders rose 44% organically and backlog (signed work not yet billed) reached $23.0 billion. Alongside the results the company set fiscal 2027 guidance: 11% to 12% organic growth and adjusted EPS of $6.15 to $6.30.
Fiscal Q4 2026 in figures
| Metric | Fiscal Q4 2026 | Fiscal Q4 2025 | YoY Change |
|---|---|---|---|
| Net sales | $7,113M | $6,442M | +10.4% |
| Organic sales growth | +12% | n/a | n/a |
| Gross margin | 38.0% | 36.5% | +1.5 pts |
| Operating margin (our calc, see note) | 16.0% | 6.7% | +9.3 pts |
| Adjusted segment EBITA margin (non-GAAP) | 20.6% | 18.8% | +1.8 pts |
| Income from continuing operations attributable to JCI | $967M | $267M | +262.2% |
| Net income attributable to JCI (incl. discontinued ops) | $967M | $1,693M | -42.9% |
| Diluted EPS, continuing operations | $1.60 | $0.42 | +281.0% |
| Adjusted EPS (non-GAAP) | $1.66 | $1.26 | +31.7% |
| Orders (organic growth) | n/a | n/a | +44% |
| Backlog (September 30) | $23.0B | n/a | +43% organic |
| Free cash flow (non-GAAP) | $1,078M | $838M | +28.6% |
Operating margin is our calculation, because JCI doesn't report an operating income line: gross profit ($2,705M) minus SG&A ($1,481M) and restructuring and impairment costs ($87M), i.e. $1,137M, divided by net sales. The prior year is $430M on $6,442M. Subtracting net financing charges ($82M) and adding equity income ($8M) ties it to the $1,063M of reported pre-tax income from continuing operations. The company's own EBIT margin, which is close to the same thing, was 16.1% versus 6.7%. The metrics card on this page uses continuing-operations figures for net income and EPS.
Full fiscal year 2026 (twelve months to September 30, 2026):
| Metric | FY2026 | FY2025 | YoY Change |
|---|---|---|---|
| Net sales | $25,666M | $23,596M | +8.8% |
| Organic sales growth | +8% | n/a | n/a |
| Adjusted segment EBITA margin (non-GAAP) | 18.8% | 17.1% | +1.7 pts |
| Diluted EPS, continuing operations | $4.72 | $2.63 | +79.5% |
| Adjusted EPS (non-GAAP) | $5.16 | $3.76 | +37.2% |
| Operating cash flow, continuing ops | $3,872M | $2,554M | +51.6% |
| Adjusted free cash flow conversion (non-GAAP) | 103% | 102% | +1 pt |
| Share repurchases | $1,505M | $5,991M | -74.9% |
Takeaway: The order book is now growing almost four times as fast as revenue: orders up 44% and backlog up 43% against 12% organic sales growth, with Americas orders up 58% on what the release calls "sustained demand for data centers." That is why management can guide fiscal 2027 organic growth to 11% to 12% with some confidence. The catch is in the guidance itself: operating leverage (how much of each extra dollar of sales becomes extra profit) is guided at 30%+, down from about 47% in fiscal 2026, so next year's growth is expected to turn into profit less efficiently.
Why GAAP profit nearly quadrupled, and why total net income fell
Two prior-year effects pull the headline numbers in opposite directions.
- Charges that didn't recur. Fiscal Q4 2025 carried $400 million of restructuring and impairment costs ($0.63 a share) and $102 million of accelerated depreciation on abandoned EMEA ERP (business software) assets ($0.16). This quarter's restructuring was $87 million. That is the main reason income from continuing operations rose from $267 million to $967 million and GAAP EPS from $0.42 to $1.60.
- A business that is gone. The year-ago quarter also included $1,426 million of income attributable to JCI from discontinued operations, chiefly the Residential and Light Commercial HVAC business sold in July 2025. That business contributed nothing this quarter, so total net income attributable to JCI fell 43%, from $1,693 million to $967 million, and total diluted EPS fell from $2.67 to $1.60.
Neither number is the operating story. The cleaner comparison is adjusted EBIT (earnings before interest and tax, excluding the company's listed one-offs), which rose 31% to $1,299 million, with the margin up from 15.3% to 18.3%.
What the headline numbers hide
- GAAP vs adjusted. This quarter the gap is small: $1.60 GAAP vs $1.66 adjusted. Excluded costs were restructuring ($87M, $0.14), transformation costs ($95M, $0.16) and transaction/separation costs ($30M, $0.05). Excluded gains were a $57M mark-to-market gain on pension and asbestos-related assets ($0.09) and $90M of discrete tax benefits ($0.15). "Transformation costs" (spending on growth and cost-saving programs) are excluded every quarter and are rising: $95M this quarter vs $56M a year ago and $292M for the year vs $180M, so "one-off" deserves skepticism.
- Tax helped GAAP and hurt adjusted. The GAAP effective tax rate was 8.7% ($93M on $1,063M of pre-tax income) thanks to that $90M of discrete tax items. On the adjusted figures the tax rate went the other way: about 17% vs about 12% a year earlier, per the release. So adjusted EPS grew 32% despite a heavier tax bill, which makes the underlying improvement look better, not worse.
- Buybacks. Diluted shares fell 4.3% (606M vs 633M) after last year's $5.0 billion accelerated buyback and $655M of repurchases this quarter. Adjusted net income rose 26% ($1,008M vs $798M), so roughly 4 of the 32 points of adjusted EPS growth came from the lower share count rather than the business.
- A lower corporate cost line. Adjusted corporate expense fell to $80M from $124M, which the release attributes to cost cuts "and the timing of certain corporate expenses." By our arithmetic the $44M saving is worth about $0.06 a share after tax at the 17% adjusted rate, a bit over half of the $0.11 beat against the ~$1.55 guidance. Some of that may reverse.
- Cash conversion is strong but leans on customers and suppliers. Operating cash flow was $1,300M in the quarter (134% of income from continuing operations) and $3,872M for the year. On the balance sheet, receivables rose 17% over the year (to $7,316M) against sales up 9%, but customer prepayments (deferred revenue, up 36% to $3,370M) and accounts payable (up 21% to $4,381M) rose faster still. That pattern fits large prepaid projects; it would reverse if order intake slowed.
- Orders definition. The release says orders before Q1 2026 "exclude certain equipment-only sales for longer cycle projects," and only backlog was restated to include them. So the year-ago orders base is narrower than this year's, and part of the 44% orders growth may come from that change. The release doesn't quantify it.
On balance the quarter is flattered: GAAP EPS rose 281% mainly because a $400M restructuring charge and a $102M write-down in the year-ago quarter didn't recur, while the underlying gain is adjusted EPS up 32%, about 4 points of it from fewer shares.
Regions
| Region | Q4 sales | Reported change | Organic change | Adj. segment EBITA margin Q4 FY26 | Adj. segment EBITA margin Q4 FY25 |
|---|---|---|---|---|---|
| Americas | $4,930M | +14% | +14% | 22.0% | 19.9% |
| EMEA | $1,312M | -2% | +3% | 16.4% | 15.6% |
| APAC | $871M | +12% | +13% | 18.9% | 17.8% |
- Americas (69% of sales) did nearly all the work: $605M of the $735M organic sales increase. Products and systems (equipment) grew 16% organically and services 10%, "led by continued strength in both Applied HVAC & Controls" (large commercial cooling systems and building controls). Orders rose 58% and backlog of $17.8B rose 54%, which the release ties to data-center demand. The margin gain came from "strong operating leverage on higher revenue and favorable business mix."
- EMEA shrank 2% on a reported basis because of divested businesses ($42M) and currency ($16M); organic growth was 3%, with "continued pressure in the region due to the conflicts in the Middle East." Equipment sales were flat; services grew 6%. Orders rose 12%.
- APAC grew 13% organically, led by 15% growth in products and systems, with orders up 11%.
Gross margin rose in both lines of business: services from 40.6% to 44.8% and products and systems from 34.7% to 35.2% (our calculation from the income statement).
Did last time's read hold up?
Our fiscal Q3 report flagged three things: whether the backlog would carry the guided 9% to 10% Q4 organic growth, whether growth concentrated in lower-margin Americas equipment would squeeze margins, and the recurring "transformation costs" outside adjusted results. The first held and then some: organic growth was 12% and adjusted EPS $1.66 vs ~$1.55 guided, and the full year landed at 8% organic growth and $5.16 adjusted EPS vs guidance of ~8% and ~$5.05. The margin worry didn't materialize this quarter: equipment gross margin edged up and the Americas segment margin rose 2.1 points. EMEA stayed weak (3% organic), and transformation costs rose again, to $95M from $80M in Q3.
Guidance and outlook
Management initiated fiscal 2027 guidance for continuing operations (all non-GAAP):
| Guidance item | Q1 FY2027 | Full-year FY2027 |
|---|---|---|
| Organic sales growth | 12% to 14% | 11% to 12% |
| Operating leverage | 30% to 35% | 30%+ |
| Adjusted EPS | $1.15 to $1.20 | $6.15 to $6.30 |
| Adjusted free cash flow conversion | n/a | ~95% |
The full-year EPS range is 19% to 22% above fiscal 2026's $5.16. By our arithmetic, fiscal 2026's operating leverage (adjusted EBIT up $967M on sales up $2,070M) was about 47%, inside the 45% to 50% guided in Q3, so the 30%+ guide implies smaller margin gains per dollar of growth next year, and cash conversion is guided slightly lower (~95% vs 103%). The balance sheet has room: net debt fell to 1.8 times adjusted EBITDA from 2.4 times a year ago.
Our read: with backlog at $23.0B and orders still outrunning sales, the growth guide is mostly a question of executing signed work, not winning new business. The risks are concentration (the Americas and data centers carry most of the growth), how much of the orders surge is the new equipment-only category, and whether margins keep rising once corporate-cost timing and easy prior-year comparisons wash out. The things to check next quarter are whether Q1 lands inside $1.15 to $1.20 with 12% to 14% organic growth, and whether EMEA organic growth moves above low single digits.
Source: this analysis is based on the fiscal Q4 2026 earnings release (Exhibit 99.1 to the 8-K filed October 27, 2026). The full fiscal 2026 annual report (Form 10-K) has not been filed yet, so management's detailed discussion of results, segment commentary beyond the release, and the restructuring program's updated cost and savings figures are not yet available.
Johnson Controls (JCI) Q4 2026 in figures
- Revenue
- $7.1B
- +10.4% YoY
- Net income
- $967M
- +262.2% YoY
- Diluted EPS
- $1.60
- +281.0% YoY
- Adjusted EPS
- $1.66
- Operating margin
- 16.0%
Capital returned: buybacks $655M · dividends $242M · diluted shares -4.3% YoY. Who is buying back most this period →
This period vs a year ago
- Same period last year
- This period
Year-ago figures (≈) are worked out from the growth rate the company reported. Each row has its own scale.
How JCI compares with Industrials peers
- JCI
- Peer median
- Each peer (hover for name)
Rank 1 = fastest revenue growth, highest operating margin, fastest EPS growth. Peers are the other Industrials companies with a 2026 report on this site, each at its latest period we've analyzed; fiscal calendars differ, so periods are not always the same months.
Get an email when we analyze Johnson Controls's next report. No newsletter, one email per report, unsubscribe in one click.
More on Johnson Controls
More Johnson Controls reports
Recent in Industrials
- Xylem Inc. (XYL) · Q3 2026Revenue $2.2B (-3.0%) · EPS $1.25 (+34.4%)
Xylem's Q3 2026 revenue fell 3.0% to $2.20B (flat organically) while GAAP EPS jumped 34% to $1.25, but adjusted pretax income fell 3.7%: a $33M tariff refund, smaller deal losses, a lower tax rate and 4.5% fewer shares did the work; orders rose 10% organically and full-year guidance was cut.
- Pentair (PNR) · Q3 2026Revenue $976M (-4.5%) · EPS $0.91 (-18.8%)
Pentair's Q3 2026 sales fell 4.5% to $976.4M as Pool dropped 17.7% at the end of distributor destocking; GAAP EPS fell 19% to $0.91 on restructuring and Taco deal charges, while adjusted EPS of $1.18 beat the $1.05–$1.08 guide.
- Paccar (PCAR) · Q3 2026Revenue $7.9B (+19.0%) · EPS $1.61 (+43.8%)
PACCAR's Q3 2026 net income rose 44% to $847.5M ($1.61 a share) on revenue up 19% to $7.94B, as U.S. and Canada truck deliveries jumped 39% from a weak year-ago quarter and the Truck segment's pre-tax margin rose to 8.1% from 2.3%; Parts profit slipped 1.4%.